I recently found myself catching up on tweets, and I came across this repost by Michael Gilman, CEO of Arrakis Therapeutics, and I was reminded that over the past 20 years we’ve seen an explosive redefinition of the edges of druggable space. The nucleus of that explosion was the human genome project. In my own […]
Expanding Druggable Space Read More »
As the country reopens, biotech companies navigate the new normal. They seek solutions for essential on-site personnel, productivity, and safe collaboration. Common strategies include hybrid work models, improved lab protocols, and increased use of virtual tools. Continuous evaluation ensures safety and efficiency.
Biotech Companies Adapting to COVID-19 Challenges: Strategies and Solutions Read More »
Every company you work for teaches you lessons. Early on in my career, I worked for a global oil & gas company. Agility isn’t typically a word one normally associates with global companies, but this was different. This was agility on a global scale. There are often cases where you need to analyze a large
During the course of evaluating the podcasts, I came across a number of issues that podcasters were running into. Issues that can make the difference between attracting the right target audience, or driving them away
Mistakes Life Science Podcasters Make Read More »
Learn how you can use podcasts to keep up to date in areas like genomics, bioinformatics, cancer research, drug discovery and drug development.
It’s the start of a new year, and nothing says New Year like a website refresh. With the rise in the number of visitors to the site using mobile browsers, we’ve updated the site to make it more mobile friendly. Not only is it more easily viewable on smartphones and tablets, but you can add
A New Year, A New Site, A New Service Read More »
At the front end of most drug discovery programs lies a step called Target Identification, and a few months ago I sat down with a colleague to discuss their approach to target identification. In particular, “how do you characterize a target”? I was surprised at how much that process can vary from company to company. As
Drug Target Identification: And then a miracle occurs Read More »
Science is inherently a collaborative effort, and at least once a month I encounter someone who mentions in passing some trial or tribulation they had when sharing documents. The story usually goes like this… We were working on a presentation/paper for a meeting. Everyone had last minute changes, new data to share, and somehow, someone
Google Docs for Scientists Read More »
Recently, I’ve been thinking about the role that social media plays in science. And while friends are fond of pointing out that I’ve drunk the Kool-Aid, colleagues at various labs usually shoot me a quizzical look when I bring up the subject. Perhaps the biggest benefit to social media is that it acts like a
Google+ For Scientists Read More »
If you’ve worked at a lab before, you’ve no doubt noticed a certain rhythm to the day. People come in early, setup their experiments, and by 10 the experiments for the day are underway, and the scientists are working on email (or Facebook), or are in the gym or are in the midst of a
Botcasting: Listening to your Journal Feeds Read More »
